Use of Alpelisib for Patients with PIK3CA-mutated advanced Breast Cancer

被引：0
|
作者：
Malter, Wolfram [1 ]
Alakus, Hakan [2 ]
Mallmann, Peter [1 ]
Bruns, Christiane [2 ]
机构：
[1] Univ Cologne, Uniklin Koln, Klin & Poliklin Frauenheilkunde & Geburtshilfe, Cologne, Germany
[2] Univ Cologne, Uniklin Koln AoR, Klin & Poliklin Allgemein Viszeral & Tumorchirurg, Kerpener Str 62, D-50937 Cologne, Germany
来源：
ONKOLOGE | 2019年 / 25卷 / 08期
关键词：
D O I：
10.1007/s00761-019-0619-9
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：724 / 725
页数：2
相关论文
共 50 条
  • [1] Alpelisib for PIK3CA-Mutated Advanced Breast Cancer
    Copur, Mehmet S.
    Jonglertham, Pornchai
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (07): : 686 - 687
  • [2] Alpelisib plus fulvestrant for PIK3CA-mutated breast cancer
    Stirrups, Robert
    [J]. LANCET ONCOLOGY, 2019, 20 (07): : E347 - E347
  • [3] Alpelisib for PIK3CA-Mutated, Hormone Receptor-Positive Advanced Breast Cancer
    Andre, Fabrice
    Ciruelos, Eva
    Rubovszky, Gabor
    Campone, Mario
    Loibl, Sibylle
    Rugo, Hope S.
    Iwata, Hiroji
    Conte, Pierfranco
    Mayer, Ingrid A.
    Kaufman, Bella
    Yamashita, Toshinari
    Lu, Yen-Shen
    Inoue, Kenichi
    Takahashi, Masato
    Papai, Zsuzsanna
    Longin, Anne-Sophie
    Mills, David
    Wilke, Celine
    Hirawat, Samit
    Juric, Dejan
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2019, 380 (20): : 1929 - 1940
  • [4] Einsatz von Alpelisib beim fortgeschrittenen PIK3CA-mutierten MammakarzinomUse of alpelisib for PIK3CA-mutated advanced breast cancer
    Wolfram Malter
    Hakan Alakus
    Peter Mallmann
    Christiane Bruns
    [J]. Der Onkologe, 2019, 25 (8): : 724 - 725
  • [5] ALPELISIB FOR RECURRENT PIK3CA-MUTATED RECURRENT CERVCIAL CANCER
    Bogani, G.
    Indini, A.
    Bini, M.
    Raspagliesi, F.
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2021, 31 : A1 - A1
  • [6] BYL719 (ALPELISIB) FOR THE TREATMENT OF PIK3CA-MUTATED, RECURRENT/ADVANCED CERVICAL CANCER
    Bogani, G.
    Bini, M.
    Ronzulli, D.
    Raspagliesi, F.
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2021, 31 : A12 - A12
  • [7] BYL719 (alpelisib) for the treatment of PIK3CA-mutated, recurrent/advanced cervical cancer
    Bogani, G.
    Indini, A.
    Bini, M.
    Raspagliesi, F.
    [J]. ANNALS OF ONCOLOGY, 2021, 32 : S754 - S754
  • [8] BYL719 (alpelisib) for the treatment of PIK3CA-mutated, recurrent/advanced cervical cancer
    Bogani, Giorgio
    Chiappa, Valentina
    Bini, Marta
    Ronzulli, Dominique
    Indini, Alice
    Conca, Elena
    Raspagliesi, Francesco
    [J]. TUMORI JOURNAL, 2023, 109 (02): : 244 - 248
  • [9] Role of Alpelisib in the Treatment of PIK3CA-Mutated Breast Cancer: Patient Selection and Clinical Perspectives
    Chang, Dwan-Ying
    Ma, Wei-Li
    Lu, Yen-Shen
    [J]. THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2021, 17 : 193 - 207
  • [10] Alpelisib for PIK3CA-mutated advanced gynecological cancers: First clues of clinical activity
    Passarelli, Anna
    Carbone, Vittoria
    Pignata, Sandro
    Mazzeo, Roberta
    Lorusso, Domenica
    Scambia, Giovanni
    Canova, Stefania
    Di Palma, Teresa
    Tasca, Giulia
    Mantiero, Mara
    Naglieri, Emanuele
    Andreetta, Claudia
    Rauso, Martina
    Brunetti, Anna Elisabetta
    Laera, Letizia
    Abeni, Chiara
    Scandurra, Giuseppa
    Gambaro, Anna Rita
    Pastore, Alessia
    Bengala, Carmelo
    Gunnellini, Marco
    Farolfi, Alberto
    Spinello, Maurizio
    Bartoletti, Michele
    [J]. GYNECOLOGIC ONCOLOGY, 2024, 183 : 61 - 67
12345